DCPS is a synthetic lethal therapeutic target in acute myeloid leukemia expressing low levels of FHIT

20251 citationsJournal Articlehybrid Open Access

Authors

Good health and well-being

Published in: Leukemia

Volume 39, Issue 8, pp. 2021-2025

Field-Weighted Citation Impact: 0.81